Trial
NCT02989870
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
National Comprehensive Cancer Network
Condition
HepatoCellular Carcinoma
Intervention
Stereotactic Body Radiation Therapy (SBRT)
Why stopped
No Interest. Investigator was unable to enroll any participants on study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-06-05